| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Nuclear Medicine Service, Veterans Administration Medical Center, Lexington 40507 [W. A. P., F. H. D.], and Division of Experimental Pathology, Department of Pathology, University of Kentucky Medical Center, and Ephraim McDowell Community Cancer Network, Inc., Lexington, Kentucky 40536 [S. J. B., D. M. G.]
Affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G was labeled with 99mTc, utilizing stannous tartrate as the reducing agent. The radiochemical yield of labeled antibody ranged from 18 to 37% and was inversely proportional to the initial quantity of pertechnetate ion used. Yields up to 60% could be obtained using small amounts of pertechnetate. the 99mTc-labeled anti-carcinoembryonic antigen immunoglobulin G preparations had a specific activity range of 1 to 6 µCi/µg protein and had 60% or greater immunoreactivity. Human serum albumin and goat immunoglobulin G were used as model systems to evaluate labeling parameters and analytical methods.
1 Presented at the UICC Workshop on Radioimmunodetection of Cancer, July 19 to 21, 1979, Lexington, Ky. Supported in part by NIH Grants CA-17742 and CA-25584, NIH Contract NIC-N01-CB-64011-35, and by a grant from the Veterans Administration.
2 To whom requests for reprints should be addressed.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |